Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTavistock Regulatory News (TAVI)

Share Price Information for Tavistock (TAVI)

Share Price is delayed by 15 minutes
Get Live Data
3.15    0.00 (0.00%)
Bid:
3.00
Ask:
3.30
Spread: 0.30 (10.00%)
Market Cap: £13.89m
TAVI Live PriceLast checked at - London Stock Exchange

Intraday Tavistock Share Chart

Issue of Options

13 Apr 2017 07:00

RNS Number : 3768C
Tavistock Investments PLC
13 April 2017
 

Tavistock Investments Plc

Issue of Performance Related Share Options

Tavistock Investments Plc ("Tavistock" or the "Company"), the financial services Group, announces that it has today issued an aggregate total of 48,500,000 performance related share options, equivalent in number to 9.09% of the shares currently in issue, to the executive directors and to other key members of the Group's management team

The exercise price of the options is 5.25p per share, which represents a premium of 86.2% over the Company's current share price of 2.82p per share. The vesting of these options is linked to the achievement of challenging and significant performance targets, in certain cases being the achievement by the Group of £5 million of pre-tax profit in a single year and in other cases being the growth of the funds managed by the Group to £1.5 billion. The options are capable of being exercised at any time within a ten-year period from the date of grant, subject to the achievement of the performance targets. Options not exercised by the end of the period will automatically lapse and will no longer be capable of exercise thereafter.

Following the issue of these options, the interests of Oliver Cooke and Brian Raven in the capital of the Company can be summarised as follows.

Name

Ordinary

Shares of 1p each

% of issued

Share Capital

Number of Option Shares

Exercise Price

Performance

Condition

Oliver Cooke

26,188,556

4.91%

1,600,000*

5.25p

Continued employment

 

 

 

5,000,000

5.25p

£5m of pre-tax profit in a single year

 

 

 

5,000,000

5.25p

£1.5b of FUM

Brian Raven

62,319,379

11.68%

1,600,000*

5.25p

Continued employment

 

 

 

5,000,000

5.25p

£5m of pre-tax profit in a single year

 

 

 

5,000,000

5.25p

£1.5b of FUM

*options issued in 2014.

 

Tavistock Investments Plc Tel: 01753 867000

Oliver Cooke

Brian Raven

Northland Capital Partners Limited Tel: 020 3861 6625

Tom Price

Matthew Johnson

Allenby Capital Limited Tel: 020 3328 5656

Nick Naylor

Nick Athanas

Templars Communications Limited Tel: 020 3642 3140

Kitty Parry

Alice Osborn

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEBUGDSISBBGRD
Date   Source Headline
29th May 20269:00 amRNSDirectorate Change
2nd Apr 20267:00 amRNSCompletion of Acquisition
30th Mar 20262:55 pmRNSChange of Auditor
5th Feb 20267:00 amRNSFurther Update on Litigation with Titan
20th Jan 20267:00 amRNSAppointment of Nominated Adviser and Broker
23rd Dec 20257:00 amRNSInterim Results
23rd Dec 20257:00 amRNSInterim Results
17th Dec 202512:13 pmRNSFurther update re ongoing litigation with Titan
16th Dec 20257:00 amRNSUpdate re ongoing litigation with Titan
6th Nov 202512:00 pmRNSResult of AGM
2nd Oct 20257:00 amRNSUpdate re ongoing litigation
30th Sep 20255:00 pmRNSTotal Voting Rights
30th Sep 20257:00 amRNSNotice of AGM
25th Sep 20257:00 amRNSTransfer of Shares from treasury to EBT and TVR
24th Sep 202510:57 amRNSDirector/PDMR Shareholding
18th Sep 20257:00 amRNSFinal Results for the Year Ended 31 March 2025
15th Sep 20252:08 pmRNSHolding(s) in Company
11th Sep 20257:00 amRNSStrategic refocus and acquisition of Lifetime
7th Jul 202512:40 pmRNSDirector / PDMR Dealing
8th Apr 20254:15 pmRNSDirector/PDMR Shareholding
12th Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20255:00 pmRNSTotal Voting Rights
20th Feb 20257:00 amRNSCompletion of acquisition of Alpha Beta Partners
14th Feb 202512:08 pmRNSDirector/PDMR Shareholding
11th Feb 20257:00 amRNSTransaction in Own Shares,Director Dealing and TVR
6th Feb 20252:16 pmRNSDirector/PDMR Shareholding
30th Jan 202511:00 amRNSHolding(s) in Company
30th Jan 20259:53 amRNSHolding(s) in Company
6th Jan 202511:54 amRNSHolding(s) in Company
2nd Jan 20255:45 pmRNSTotal Voting Rights - Replacement
31st Dec 20241:30 pmRNSTotal Voting Rights
12th Dec 202412:00 pmRNSTransaction in Own Shares and Total Voting Rights
11th Dec 202411:30 amRNSResult of AGM
9th Dec 202412:49 pmRNSTransaction in Own Shares and Total Voting Rights
9th Dec 20247:00 amRNSInterim Results
2nd Dec 20247:00 amRNSRepositioning of Retail Asset Management business
22nd Nov 20247:00 amRNSStrategic acquisition and completion of disposal
11th Nov 20243:38 pmRNSNotice of AGM
30th Oct 202411:25 amRNSResult of General Meeting
2nd Oct 20243:50 pmRNSPublication of Circular and Notice of GM
2nd Oct 202411:32 amRNSDirector/PDMR Shareholding
1st Oct 20247:00 amRNSProposed disposals for up to £37.75 million
30th Sep 20247:00 amRNSFinal Results for the Year Ended 31 March 2024
19th Sep 20242:47 pmRNSUpdate on Titan Dispute
11th Jul 20247:00 amRNSFollow up to Titan termination announcement
8th Jul 20244:19 pmRNSTermination of strategic partnership
28th Jun 202410:16 amRNSStatement re press speculation
21st Jun 202410:31 amRNSDirectorate Change
31st May 20247:00 amRNSBoard role change
8th Jan 20247:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.